LTRN Shares Outstanding History



Below is a table of the LTRN shares outstanding history going back to 6/11/2020:

Date LTRN Shares Outstanding
6/11/20206.03M
7/29/20206.22M
10/28/20206.22M
3/8/202111.17M
4/30/202111.18M
7/22/202111.18M
10/29/202111.19M
3/1/202210.78M
4/28/202210.83M
8/1/202210.83M
11/1/202210.86M
3/6/202310.86M
5/3/202310.86M
8/2/202310.87M
11/3/202310.87M
3/5/202410.74M

Also see: LTRN Market Cap History
LTRN YTD Return
LTRN Historical Shares Outstanding:
+16.72% CAGR
LTRN Historical Shares Outstanding: +16.72% CAGR

Mouse over chart for data details
6/11/2020 ...3/5/2024
Lantern Pharma is a biotechnology company, focused on utilizing artificial intelligence, machine learning and genomic data. Co.'s drug candidates include: LP-300, which is a cysteine-modifying molecular entity that works to modulate multiple cellular pathways and is a combination agent for targeted indications in non-small cell lung cancer; LP-184, which preferentially damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways; LP-284, which is for the treatment of several non-Hodgkin's lymphomas including mantle cell lymphoma and double hit lymphoma; and LP-100, which exploits cancer cells' deficiency in DNA repair mechanisms. We show 16 historical shares outstanding datapoints in our coverage of LTRN's shares outstanding history.

Understanding the changing numbers of LTRN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LTRN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LTRN by allowing them to research LTRN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree LTRN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Lantern Pharma (LTRN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

LUCD Shares Outstanding History
LUMO Shares Outstanding History
LUNG Shares Outstanding History
LVGO Shares Outstanding History
LXEO Shares Outstanding History
LXRX Shares Outstanding History
LYEL Shares Outstanding History
LYRA Shares Outstanding History
MACK Shares Outstanding History
MASI Shares Outstanding History
More Healthcare companies »

 

LTRN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.